Filter Results:
(334)
Show Results For
- All HBS Web
(334)
- News (103)
- Research (167)
- Events (2)
- Multimedia (4)
- Faculty Publications (84)
Show Results For
- All HBS Web
(334)
- News (103)
- Research (167)
- Events (2)
- Multimedia (4)
- Faculty Publications (84)
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
like a trained oncologist? How about setting up an online competition to find out? An article being published April 18 in JAMA Oncology, a journal of the American Medical Association, describes the crowdsourcing contest and the potential View Details
- 28 Mar 2023
- Research & Ideas
The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation
“The findings of our study suggest that regulatory innovation can support more efficient drug development—in particular, in settings where we have unmet medical needs. ” In the first comprehensive analysis of its kind, Harvard Business... View Details
- February 2024
- Case
Innovation Strategy at Stanley Black & Decker: Setting the Direction for Growth
By: David L. Ager and Antonio Manuel Oftelie
On July 1, 2022, Don Allan was appointed Chief Executive Officer of Stanley Black & Decker (SBD). Although Allan had been with the firm for 23 years, most recently serving as President and Chief Financial Officer, he recognized that he was stepping into his new role as... View Details
Keywords: Health Pandemics; Collaborative Innovation and Invention; Innovation Leadership; Growth Management; Business and Stakeholder Relations
Ager, David L., and Antonio Manuel Oftelie. "Innovation Strategy at Stanley Black & Decker: Setting the Direction for Growth." Harvard Business School Case 924-301, February 2024.
- Web
Fostering Innovation in Life Sciences - Health Care
Impact Fostering Innovation in Life Sciences Gaining Ground on ALS Re: Rob Blum (MBA 1991) Health Minute: How Can Technology Improve 21st Century Health Care Health Minute: How Can Companies Bring "Missing Drugs" to Market? More “Life... View Details
- 26 Jan 2004
- Research & Ideas
What Developing-World Companies Teach Us About Innovation
goal is to reach 800,000 more within five years. Innovate Around—rather Than Through—the Technology Companies such as Samsung or Novartis can drive innovation from their R&D labs, continually translating... View Details
- 01 Mar 2016
- News
The HBS Fund for Leadership and Innovation
the world, but the School can never rest on its legacy; rather, it must be relentless in its pursuit of excellence and relevance. Annual giving to the HBS Fund for Leadership and Innovation helps make this possible. “The School relies... View Details
- Article
The Board's New Innovation Imperative: Directors Need to Rethink Their Roles and Their Attitude to Risk
By: Linda A. Hill and George Davis
As firms scramble for competitive advantage, boards—once the cautious voices urging management to mitigate risk—are now calling for breakthrough innovation. Indeed, avoiding risk is now seen as the riskiest proposition of all. In speaking with CEOs and board members... View Details
Keywords: Governing and Advisory Boards; Innovation Leadership; Risk and Uncertainty; Corporate Governance
Hill, Linda A., and George Davis. "The Board's New Innovation Imperative: Directors Need to Rethink Their Roles and Their Attitude to Risk." Harvard Business Review 95, no. 6 (November–December 2017): 102–109.
- 12 Sep 2022
- Research & Ideas
When Experts Play It Too Safe: Innovation Lessons from a NASA Experiment
breakthroughs may hit the discard pile before companies can evaluate them in full—causing companies to miss out on big competitive leaps, write the researchers in their working paper. Lane, who is affiliated with the Laboratory for View Details
- March 2018 (Revised September 2023)
- Case
X: The Foghorn Decision
In February 2016, Kathy Hannun—a project leader at X, Alphabet Inc.'s so-called "moonshot factory"—had to prepare a recommendation for the senior leadership of X regarding the future of Foghorn, a project she was leading to develop a carbon-neutral process for... View Details
Keywords: Innovation; R&D Project Management; Radical Innovation; Clean Technology; Innovation and Management; Technological Innovation; Energy; Research and Development; Projects; Management; Decision Choices and Conditions; Technology Industry; Energy Industry; Green Technology Industry; California
Huckman, Robert S., Karim R. Lakhani, and Kyle R. Myers. "X: The Foghorn Decision." Harvard Business School Case 618-060, March 2018. (Revised September 2023.)
Think Outside the Building: How Advanced Leaders Can Change the World One Smart Innovation at a Time
One of the leading business thinkers in the world offers a bold, new theory of advanced leadership for tackling the world's complex, messy, and recalcitrant social and environmental problems.
Over a decade ago, renowned innovation... View Details
Over a decade ago, renowned innovation... View Details
- 20 Mar 2017
- Book
Why Companies Are Placing Users at the Core of Their Innovation Strategies
Gerdeman: Can you touch on the implications user innovation has on competition? Lakhani: In many ways, what the research is showing is that companies can reliably work with external sources of innovation—users, communities, even... View Details
Keywords: by Dina Gerdeman
- May 2019
- Case
The United States Air Force: 'Chaos' in the 99th Reconnaissance Squadron
By: Francesca Gino, Jeff Huizinga and Nicole Keller
In the spring of 2019, Lt. Col. Matthew “Chaos” Nussbaum is nearing the end of his two-year term as commander of the U.S. Air Force's 99th Reconnaissance Squadron. In this position, he has focused the majority of his energy on finding new ways to organize, train, and... View Details
Keywords: Empowerment; Culture; Innovation; Motivation; Military; Leadership; Organizational Culture; Change; Leading Change; Innovation Strategy; United States
Gino, Francesca, Jeff Huizinga, and Nicole Keller. "The United States Air Force: 'Chaos' in the 99th Reconnaissance Squadron." Harvard Business School Case 919-047, May 2019.
- March 2013 (Revised May 2013)
- Case
Omar Ishrak: Building Medtronic Globally
By: Bill George and Natalie Kindred
Omar Ishrak, Medtronic's first non-American CEO, aims to reinvigorate the medical device maker's growth by focusing on emerging markets, therapy innovation, and creative business models. In 2012, budget constraints in mature economies, the lack of new medical therapies... View Details
Keywords: Healthcare; Medical Devices; Medtronic; Globalization; Innovation; Reverse Innovation; Leadership; Multinational Firms and Management; Globalized Markets and Industries; Management Teams; Business Model; Emerging Markets; Global Strategy; Health Care and Treatment; Acquisition; Innovation and Invention; Manufacturing Industry; Medical Devices and Supplies Industry; China
George, Bill, and Natalie Kindred. "Omar Ishrak: Building Medtronic Globally." Harvard Business School Case 413-065, March 2013. (Revised May 2013.)
- Research Summary
Overview
By: Roberto Verganti
Roberto’s research focuses on how to create innovations that are meaningful for people, for society, and for their creators. He explores how leaders and organizations generate radically new visions, and make those visions come real. His studies lie at the intersection... View Details
- 05 Apr 2022
- Blog Post
The HBS New Venture Competition Turns 25: Celebrating A Quarter Century of Innovation and Entrepreneurship
prize. Viewers also had the opportunity to select a crowd favorite in each of the three tracks, with a prize value of $5,000. In a separate process that recognizes the unique challenges of companies commercializing breakthrough... View Details
- September 2024
- Case
Myeloma Investment Fund
By: Kyle Myers and Scott Sawaya
This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma.
The MIF, a venture philanthropy fund, must choose between two distinct paths. One option... View Details
Keywords: Venture Philanthropy; Biomedical Research; Science Bassed Business; Investing For Impact; Innovation & Entrepreneurship; Venture Capital; Science-Based Business; Biotechnology Industry; Pharmaceutical Industry
Myers, Kyle, and Scott Sawaya. "Myeloma Investment Fund." Harvard Business School Case 625-047, September 2024.
- May–June 2015
- Other Article
The Challenges of Ambidextrous Leadership: An Interview with Michael Tushman
By: Michael Tushman and Jim Euchner
Michael Tushman talks with Jim Euchner about the challenges of managing breakthrough innovation in established companies. View Details
Keywords: Innovation and Management
Tushman, Michael, and Jim Euchner. "The Challenges of Ambidextrous Leadership: An Interview with Michael Tushman." Research-Technology Management 58, no. 3 (May–June 2015): 16–20.
- 12 Dec 2011
- HBS Case
HBS Cases: Clocky, the Runaway Alarm Clock
same time, Harvard Business School Professor Elie Ofek was seeking case studies for his second-year Marketing and Innovation course. "I was looking for new products and innovations that were unexpected... View Details